{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:37:14Z","timestamp":1771879034313,"version":"3.50.1"},"reference-count":64,"publisher":"Impact Journals, LLC","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,6]]},"DOI":"10.18632\/oncotarget.10759","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T19:41:39Z","timestamp":1469130099000},"page":"57752-57769","source":"Crossref","is-referenced-by-count":34,"title":["Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors"],"prefix":"10.18632","volume":"7","author":[{"given":"Jung Min","family":"Song","sequence":"first","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunkumar","family":"Anandharaj","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Upadhyaya","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameya R.","family":"Kirtane","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hyuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"},{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwon Ho","family":"Hong","sequence":"additional","affiliation":[{"name":"Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN 55414, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayanth","family":"Panyam","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"},{"name":"Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fekadu","family":"Kassie","sequence":"additional","affiliation":[{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA"},{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21340","article-title":"Cancer Statistics 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA cancer j clin"},{"key":"2","first-page":"5","article-title":"Chinese and Related North American Herbs","author":"Li","year":"2002","journal-title":"CRC Press"},{"key":"3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/jcb.22098","article-title":"Magnolol induces apoptosis via inhibiting the EGFR\/PI3K\/Akt signaling pathway in human prostate cancer cells","volume":"106","author":"Lee","year":"2009","journal-title":"J Cell Biochem"},{"key":"4","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.3748\/wjg.v10.i23.3459","article-title":"Honokiol: a potent chemotherapy candidate for human colorectal carcinoma","volume":"10","author":"Hu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2008.11.029","article-title":"Down-regulation of c-Src\/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells","volume":"277","author":"Lee","year":"2009","journal-title":"Cancer Lett"},{"key":"6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4161\/epi.23078","article-title":"Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell deathand","volume":"8","author":"Katiyar","year":"2013","journal-title":"Epigenetics"},{"key":"7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijpharm.2011.03.003","article-title":"Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol","volume":"410","author":"Chen","year":"2011","journal-title":"Int J Pharm"},{"key":"8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1471-2407-8-242","article-title":"Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model","volume":"8","author":"Wei","year":"2008","journal-title":"BMC Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"940405","DOI":"10.1155\/2012\/940405","article-title":"Genetic and biochemical alterations in non-small cell lung cancer","volume":"2012","author":"Chellappan","year":"2012","journal-title":"Biochem Res Int"},{"key":"10","article-title":"A comprehensive pathway map of epidermal growth factor receptor signaling","volume":"1","author":"Kitano","year":"2005","journal-title":"Mol Syst Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1158\/1940-6207","article-title":"Deregulated EGFR signaling during lung cancer progression: mutations amplicons and autocrine loops","volume":"1","author":"Minna","year":"2008","journal-title":"Cancer Prev Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signaling: towards the systems level","volume":"7","author":"Yarden","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"13","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-05-2291","article-title":"Analysis of c-ErbB1\/epidermal growth factor receptor and c-ErbB2\/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer","volume":"12","author":"Hirsch","year":"2006","journal-title":"Clin Cancer Res"},{"key":"14","first-page":"1365","article-title":"Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and co-expression precedes squamous cell carcinoma development","volume":"55","author":"Dmitrovsky","year":"1995","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1158\/1940-6207","article-title":"Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas","volume":"1","author":"Wistuba","year":"2008","journal-title":"Cancer Prev Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1158\/1078-0432","article-title":"Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers","volume":"14","author":"J\u00e4nne","year":"2008","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1200\/JCO.2008.21.3744","article-title":"Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab","volume":"27","author":"De Hertogh","year":"2009","journal-title":"J Clin Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1200\/JCO.2010.31.0805","article-title":"Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR21","volume":"28","author":"Bradbury","year":"2010","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"13528","DOI":"10.1073\/pnas.1101835108","article-title":"Structural conservation of druggable hot spots in protein-protein interfaces","volume":"108","author":"Vajda","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"20","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1073\/pnas.89.15.6693","article-title":"A tobaccospecific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells","volume":"89","author":"Harris","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"21","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1349-7006.2008.00875.x","article-title":"Induction of lung adenocarcinoma in transgenic mice expressing activated EGFR driven by the SP-C promoter","volume":"99","author":"Kiura","year":"2008","journal-title":"Cancer Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1158\/0008-5472.CAN-08-4205","article-title":"Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice","volume":"69","author":"Kiura","year":"2009","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1541-7786.MCR-06-0086","article-title":"Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer","volume":"4","author":"You","year":"2006","journal-title":"Mol Cancer Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1158\/0008-5472.CAN-05-1977","article-title":"High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor","volume":"65","author":"Peyton","year":"2005","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lungcan.2008.11.021","article-title":"Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A\/J mice","volume":"65","author":"Tanimoto","year":"2009","journal-title":"Lung Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lungcan.2010.01.004","article-title":"Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression","volume":"70","author":"Miller","year":"2010","journal-title":"Lung Cancer"},{"key":"27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00280-007-0644-z","article-title":"Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice","volume":"62","author":"Malkinson","year":"2008","journal-title":"Cancer chemother Pharmacol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s40265-015-0434-6","article-title":"Expert consensus on the management of adverse events from EGFR tyrosine kinase inhibitors in the UK","volume":"75","author":"Nicolson","year":"2015","journal-title":"Drugs"},{"key":"29","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1245\/s10434-014-3878-0","article-title":"Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients","volume":"21","author":"Nabell","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"21268","DOI":"10.18632\/oncotarget.4178","article-title":"Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor","volume":"6","author":"Katiyar","year":"2015","journal-title":"Oncotarget"},{"key":"31","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1158\/1078-0432.CCR-10-0333","article-title":"Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors","volume":"16","author":"Grandis","year":"2010","journal-title":"Clin Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.phymed.2014.07.011","article-title":"Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking","volume":"21","author":"Efferth","year":"2014","journal-title":"Phytomedicine"},{"key":"33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1165\/ajrcmb.20.5.3308","article-title":"Expression of c-erbB receptors and ligands in human bronchial mucosa","volume":"20","author":"Davies","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1096\/fasebj.14.10.1362","article-title":"Involvement of the epidermal growth factor receptor in epithelial repair in asthma","volume":"14","author":"Davies","year":"2000","journal-title":"FASEB J"},{"key":"35","doi-asserted-by":"crossref","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","article-title":"Epithelial repair mechanisms in the lung","volume":"298","author":"Waters","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1165\/ajrcmb.26.4.4594","article-title":"Dose-related protection from nickel-induced lung injury in transgenic mice expressing human transforming growth factor-alpha","volume":"26","author":"Korfhagen","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/eci.12178","article-title":"Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction","volume":"43","author":"Tzortzaki","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3892\/ol.2012.872","article-title":"Molecular mechanisms of lung-specific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors","volume":"4","author":"Tatsumi","year":"2012","journal-title":"Oncol Lett"},{"issue":"Suppl 2","key":"39","first-page":"S31","article-title":"Understanding the mechanisms of drug-associated interstitial lung disease","volume":"91","author":"Fujita","year":"2004","journal-title":"Br J Cancer"},{"key":"40","first-page":"824","article-title":"Pulmonary toxicities of tyrosine kinase inhibitors","volume":"9","author":"Daw","year":"2011","journal-title":"Clin Adv Hematol Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.07-0050","article-title":"Pulmonary toxicity associated with erlotinib","volume":"132","author":"Azzoli","year":"2007","journal-title":"Chest"},{"key":"42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/1541-7786.MCR-12-0558","article-title":"Molecular dissection of AKT activation in lung cancer cell lines","volume":"11","author":"Kwiatkowski","year":"2013","journal-title":"Mol Cancer Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Sliwkowski","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2006.05.024","article-title":"Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer","volume":"10","author":"Yao","year":"2006","journal-title":"Cancer Cell"},{"key":"45","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.22903","article-title":"Epidermal growth factor ligand\/receptor loop and downstream signaling activation pattern in completely resected non small cell lung cancer","volume":"110","author":"Scagliotti","year":"2007","journal-title":"Cancer"},{"key":"46","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1158\/1535-7163.MCT-06-0759","article-title":"Expression of epidermal growth factor (EGF)\/transforming growth factor-\u03b1 by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice","volume":"6","author":"Herbst","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/excr.1996.0081","article-title":"Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells","volume":"223","author":"Viallet","year":"1996","journal-title":"Exp Cell Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"ra45","DOI":"10.1126\/scisignal.2004015","article-title":"AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve","volume":"6","author":"Blenis","year":"2013","journal-title":"Sci Signal"},{"key":"49","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1091\/mbc.12.6.1897","article-title":"Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking","volume":"12","author":"Wiley","year":"2001","journal-title":"Mol Biol Cell"},{"key":"50","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/0008-5472.CAN-08-4055","article-title":"PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR","volume":"69","author":"Mermel","year":"2009","journal-title":"Cancer Res"},{"key":"51","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.18632\/oncotarget.1431","article-title":"Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells","volume":"4","author":"Chen","year":"2013","journal-title":"Oncotarget"},{"key":"52","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/carcin\/16.10.2487","article-title":"K-ras mutations in lung tumors from A\/J and A\/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate","volume":"16","author":"You","year":"1995","journal-title":"Carcinogenesis"},{"key":"53","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/sj.onc.1208390","article-title":"Tobacco smoke-induced lung tumorigenesis in mutant A\/J mice with alterations in K-ras p53 or Ink4a\/Arf","volume":"24","author":"You","year":"2005","journal-title":"Oncogene"},{"key":"54","first-page":"2877","article-title":"K-ras mutations in lung tumors from NNK-treated mice with lipopolysaccharide-elicited lung inflammation","volume":"31","author":"DI","year":"2011","journal-title":"Anticancer Res"},{"key":"55","first-page":"57","article-title":"KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib","volume":"2","author":"Varmus","year":"2005","journal-title":"PLoS Med"},{"key":"56","first-page":"2903","article-title":"ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis","volume":"52","author":"Sasazuki","year":"1992","journal-title":"Cancer Res"},{"key":"57","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2174\/156652412803833508","article-title":"Honokiol: a novel natural agent for cancer prevention and therapy","volume":"12","author":"Singh","year":"2012","journal-title":"Curr Mol Med"},{"key":"58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/15680096113136660108","article-title":"Dimethylaminoparthenolide a water soluble parthenolide suppresses lung tumorigenesis through down-regulating the STAT3 signaling pathway","volume":"14","author":"Kassie","year":"2014","journal-title":"Curr Cancer Drug Targets"},{"key":"59","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/carcin\/bgs390","article-title":"Chemoprevention of lung tumorigenesis by intranasally administered diindolylmethane in A\/J mice","volume":"34","author":"Kassie","year":"2013","journal-title":"Carcinogenesis"},{"key":"60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/carcin\/4.3.305","article-title":"Effects of \u03b1-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)","volume":"4","author":"Castonguay","year":"1983","journal-title":"Carcinogenesis"},{"key":"61","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/carcin\/bgv054","article-title":"Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators","volume":"36","author":"Kassie","year":"2015","journal-title":"Carcinogenesis"},{"key":"62","unstructured":"Schrodinger Suite 2015 Protein Preparation Wizard Epik version 2.4 Schrodinger. LLC, New York NY. 2015. Impact version 5.8 Schrodinger LLC New York NY 2015 Prime version 3.2 Schrodinger LLC New York NY 2015."},{"key":"63","unstructured":"Glide version 6.6 Schrodinger. LLC, New York NY. 2015."},{"key":"64","unstructured":"Desmond Molecular Dynamics System version 3.0. D E Shaw Research, New York NY. 2011."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:19:26Z","timestamp":1596712766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":64,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016,9,6]]}},"alternative-id":["10759","27458163"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10759","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}